UPDATE 2-Teva Pharm to pay Oklahoma $85 mln to settle opioid claims

UPDATE 2-Teva Pharm to pay Oklahoma $85 mln to settle opioid claimsBOSTON/JERUSALEM, May 26 (Reuters) - Teva Pharmaceutical Industries Ltd said on Sunday it had agreed to pay an $85 million settlement with the state of Oklahoma days before the company was set to face trial over allegations that it and other drugmakers helped fuel the U.S. opioid epidemic. Teva, the world's largest generic drugmaker, said the settlement "does not establish any wrongdoing on the part of the company" and denied contributing to opioid abuse in Oklahoma. Claims against Teva focused on the branded opioid products Actiq and Fentora as well as generic painkillers it produced.




from Yahoo News - Latest News & Headlines https://yhoo.it/2X74wix
via Latest News

Comments

Post a Comment

Popular posts from this blog

Facebook's latest bug exposed the private photos of 6.8 million users - The INQUIRER

Facebook's latest bug exposed the private photos of 6.8 million users    The INQUIRER After a year from hell, Facebook parties like it's 2017    The Guardian Facebook bug may have exposed users’ photos    ConsumerAffairs Bug may have exposed photos from 7 million Facebook users | WSB-TV    WSB Atlanta Use This Tool To See If Your Photos Were Exposed In Facebook's Latest Privacy Blunder    Hot Hardware View full coverage on Google News from Technology - Latest - Google News https://ift.tt/2Bs7iVW via Technology
Read more

Overwatch 2 Anime Charm Is Cheaper In Real Life Than In The Game - Kotaku

Overwatch 2 Anime Charm Is Cheaper In Real Life Than In The Game    Kotaku Blizzard Sells an Overwatch 2 Charm Cheaper in Real Life Than In-Game    IGN Real life Overwatch 2 charm costs less than it does in game    PCGamesN Overwatch 2 Fans Upset at Blizzard's Reasoning for Not Nerfing Sojourn    GameRant Overwatch 2: Keychain Costs More In-Game Than Real Life    DualShockers View Full Coverage on Google News from Technology - Latest - Google News https://ift.tt/P970ArQ via Technology
Read more